Clinical Trials Logo
  1. Home
  2. Lymph Node Metastases
  3. NCT04322331

Tumor Immune Mechanism of Axillary Lymph Node Metastasis in Early Luminal Type A Breast Cancer

Lymph Node Metastases Clinical Trial

Official title:
The Different Transcriptional Characterization Of The Tumor Immune Microenvironment of Luminal A Breast Cancer With Different Lymph Node Metastasas Status

Clinical Trial Summary

Luminal type A breast cancer is a type with good clinical prognosis, and the proportion of lymph node metastasis is low, but a small number of patients have more lymph node metastasis when the primary tumor is very small, and the survival is poor, suggesting that this part of Luminal A breast cancer has the different expression of some genes from that of general Luminal A breast cancer, which affects tumor invasion and participates in the occurrence of tumor metastasis. But the mechanism is not clear, especially in the current tumor microenvironment and immune related mechanisms.We want to investigated the relationship of the transcriptional tumor immune microenvironment with early lymph node metastasis among Luminal A type breast cancer.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04322331
Study type Observational
Source Peking University People's Hospital
Contact
Status Enrolling by invitation
Phase
Start date May 1, 2020
Completion date December 31, 2021
View Details
See also
  Status Clinical Trial Phase
Completed NCT03280719 - Whole Breast + Lymph Node Irradiation: Prone Compared to Supine Position in 15 or 5 Fractions N/A
Active, not recruiting NCT04300673 - Radio Guided Lymph Node Dissection in Oligometastatic Prostate Cancer Patients Phase 1/Phase 2
Completed NCT04260139 - Lymph Node Yield in Colon Cancer Resection Specimens
Not yet recruiting NCT03632746 - Verifying the Specificity of a New Method in Predicting Lymph Node Metastasis in Early Gastric Cancer Patients
Recruiting NCT03776591 - Open D3 Right Hemicolectomy Compared to Laparoscopic CME for Right Sided Colon Cancer N/A
Recruiting NCT05078853 - Thyroglobulin Point of Care Assay for Rapid Detection of Metastatic Differentiated Thyroid Carcinoma
Recruiting NCT03715686 - To Accurately Assess Lymph Node Response to NACT by Wire Localization of Clip-marked Lymph Nodes N/A
Recruiting NCT03280134 - A Prospective Validation Cohort Study of a Prediction System on nSLN Metastasis in Early Breast Cancer N/A
Recruiting NCT04117139 - The Diagnostic Value of PET/MRI in Head and Neck Cancer N/A
Recruiting NCT04882618 - Use of Indocyanine Green During Pelvic Lymph Node Dissection in Prostate Cancer. Phase 4
Recruiting NCT05670574 - Surgery With Extended (D3) Mesenterectomy for Small Bowel Tumors N/A
Active, not recruiting NCT04611997 - IGG Using in Laparoscopic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy Phase 3
Recruiting NCT04744506 - Targeted Resection of Axillary Metastatic Lymph Nodes After Breast Cancer Neoadjuvant Chemotherapy N/A
Recruiting NCT03830242 - Diagnostic Significance of FDG PET/CT Dynamic Imaging in Detecting Metastatic Lymph Nodes With Papillary Thyroid Cancer. N/A
Recruiting NCT04959604 - Lymph Node Mapping Via Flourescent Dye in Colon Cancer N/A
Active, not recruiting NCT04419935 - Lymphadenectomy in NSCLC With and Without Adjuvant Therapy
Recruiting NCT03868215 - Use of Plasma ctDNA Methylation Haplotypes in Detecting Local Residual or Lymph Node Metastasis
Recruiting NCT04337333 - Two-in-one Covered and Uncovered Metal Stent N/A
Completed NCT04068636 - Sentinel Node in Larynx and Pharynx Cancers N/A
Recruiting NCT04671511 - Targeted Axillary Dissection (TAD) in Early-stage Node Positive Breast Cancer N/A